Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -6.75%705M | 5.10%742M | 3.23%447M | 6.10%2.47B | -19.72%574M | 16.13%756M | 1.44%706M | 63.40%433M | 17.41%2.33B | 5.61%715M |
| Net income from continuing operations | 54.51%428M | -64.81%297M | -8.41%425M | -17.16%2.19B | -6.62%607M | -25.14%277M | -5.06%844M | -37.04%464M | 90.22%2.65B | 263.13%650M |
| Operating gains losses | -239.47%-106M | 415.15%104M | 270.59%63M | 85.95%-151M | -115.00%-215M | -13.64%76M | 94.74%-33M | 103.89%17M | -1,164.71%-1.08B | -167.57%-100M |
| Depreciation and amortization | 15.84%234M | 11.65%230M | 9.71%226M | 13.38%822M | 10.05%208M | 9.78%202M | 15.08%206M | 19.08%206M | 0.14%725M | 2.72%189M |
| Deferred tax | 312.50%33M | 99.82%-1M | 112.67%19M | -64.95%-640M | 347.37%47M | 103.19%8M | -6,155.56%-545M | -18.11%-150M | -385.00%-388M | -116.81%-19M |
| Other non cashItems | 169.23%9M | -88.89%5M | -82.05%7M | 284.21%70M | 106.67%3M | -533.33%-13M | 650.00%45M | 4,000.00%39M | -258.33%-38M | -550.00%-45M |
| Change In working capital | -48.06%107M | -43.39%107M | -104.90%-293M | -61.49%176M | -290.00%-76M | -19.84%206M | -21.25%189M | -78.75%-143M | 5,612.50%457M | -6.98%40M |
| -Change in receivables | -58.82%28M | 56.14%-25M | -48.51%52M | 131.33%26M | 34.85%-86M | 277.78%68M | 3.39%-57M | 12.22%101M | -196.43%-83M | -43.48%-132M |
| -Change in prepaid assets | -65.96%16M | 92.86%-1M | 466.67%17M | -96.08%2M | -580.00%-34M | 113.64%47M | -240.00%-14M | -87.50%3M | 2,650.00%51M | 85.29%-5M |
| -Change in payables and accrued expense | 13.25%94M | -90.61%17M | -81.82%-280M | -70.80%139M | -81.41%29M | -65.84%83M | -12.14%181M | -19.38%-154M | 5,188.89%476M | 0.65%156M |
| -Change in other working capital | -487.50%-31M | 46.84%116M | 11.83%-82M | -30.77%9M | -28.57%15M | 130.77%8M | -4.82%79M | -43.08%-93M | -55.17%13M | 50.00%21M |
| Cash from discontinued investing activities | -1M | 500.00%4M | -100.00%-2M | -185.71%-12M | 0.00%-10M | 0 | 0.00%-1M | -150.00%-1M | 120.90%14M | -900.00%-10M |
| Operating cash flow | -6.88%704M | 5.82%746M | 3.01%445M | 4.96%2.46B | -20.00%564M | 12.17%756M | 1.44%705M | 61.80%432M | 22.25%2.34B | 4.29%705M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 31.55%-141M | -156.17%-182M | -219.81%-756M | -80.65%680M | 69.06%-69M | -147.36%-206M | -80.17%324M | -62.17%631M | 887.89%3.51B | -448.44%-223M |
| Capital expenditure reported | -8.72%-162M | -7.24%-163M | -4.14%-151M | -11.58%-607M | -21.97%-161M | -2.76%-149M | -19.69%-152M | -3.57%-145M | 8.57%-544M | 2.22%-132M |
| Net business purchase and sale | 575.00%54M | -103.21%-19M | -176.52%-606M | -66.32%1.56B | 943.75%167M | -99.05%8M | -69.97%591M | -56.07%792M | 6,702.94%4.63B | -92.20%16M |
| Net other investing changes | 49.23%-33M | ---- | 106.25%1M | 52.29%-271M | 29.91%-75M | 74.90%-65M | 44.44%-115M | -420.00%-16M | -801.23%-568M | -1,683.33%-107M |
| Cash from discontinued investing activities | 0 | 0 | 0 | 0 | 93.75%-1M | 0 | ||||
| Investing cash flow | 31.55%-141M | -156.17%-182M | -219.81%-756M | -80.64%680M | 69.06%-69M | -147.36%-206M | -80.16%324M | -62.17%631M | 860.39%3.51B | -448.44%-223M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -23.37%-607M | -2.41%-1.28B | 38.72%-288M | 56.29%-2.46B | 85.19%-252M | 66.05%-492M | -7.33%-1.25B | 64.26%-470M | -386.68%-5.63B | -1,189.39%-1.7B |
| Net issuance payments of debt | 226.07%324M | -41.17%-1.02B | -103.39%-17M | 69.52%-492M | 98.49%-17M | 79.05%-257M | -164.37%-719M | 232.89%501M | -265.20%-1.61B | -271.28%-1.13B |
| Net common stock issuance | ---670M | --0 | --0 | 79.55%-639M | --0 | --0 | 85.97%-287M | 50.97%-352M | -143.68%-3.12B | 38.18%-361M |
| Cash dividends paid | -10.13%-261M | -10.13%-261M | -9.24%-260M | -6.39%-949M | -9.72%-237M | -8.22%-237M | -2.16%-237M | -5.78%-238M | -6.57%-892M | -3.85%-216M |
| Net other financing activities | ---- | 150.00%1M | 97.11%-11M | -9,575.00%-379M | 0.00%2M | 166.67%2M | ---2M | -7,720.00%-381M | 128.57%4M | 0.00%2M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -23.37%-607M | -2.41%-1.28B | 38.72%-288M | 56.29%-2.46B | 85.19%-252M | 66.05%-492M | -7.33%-1.25B | 64.26%-470M | -386.68%-5.63B | -1,189.39%-1.7B |
| Net cash flow | ||||||||||
| Beginning cash position | -60.24%664M | -27.42%1.37B | 51.62%1.97B | 21.42%1.3B | -31.20%1.73B | -41.57%1.67B | 11.78%1.89B | 21.42%1.3B | 37.40%1.07B | 448.15%2.52B |
| Current changes in cash | -175.86%-44M | -229.17%-711M | -201.01%-599M | 197.37%678M | 119.92%243M | 117.06%58M | -118.49%-216M | -4.35%593M | -23.23%228M | -300.66%-1.22B |
| Effect of exchange rate changes | -166.67%-2M | 233.33%4M | 200.00%2M | -900.00%-8M | -400.00%-6M | 250.00%3M | ---3M | -300.00%-2M | 116.67%1M | 0.00%2M |
| End cash Position | -64.30%618M | -60.24%664M | -27.42%1.37B | 51.62%1.97B | 51.62%1.97B | -31.20%1.73B | -41.57%1.67B | 11.78%1.89B | 21.42%1.3B | 21.42%1.3B |
| Free cash from | -10.71%542M | 5.42%583M | 2.44%294M | 2.95%1.85B | -29.67%403M | 14.74%607M | -2.64%553M | 125.98%287M | 36.14%1.8B | 5.91%573M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.